Protective effect of PEG-SOD against early coronary reperfusion injury assessed in reperfused and non-reperfused ischaemic areas of the same heart

Acta Cardiologica

Volumn 56, Issue 3, 2001, Pages 181-186

  Kanamasa, K ^a   Ishida, N ^a   Ishikawa, K ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Myocardial blood flow; Myocardial CPK; PEG SOD; Reperfusion injury

Indexed keywords

SUPEROXIDE DISMUTASE MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY REPERFUSION; DOG; DRUG EFFECT; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; NONHUMAN; REPERFUSION INJURY;

EID: 0034951734     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.56.3.2005638     Document Type: Article

References (29)

1. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon
2. Identification of a time window for therapy to reduce experimental canine myocardial injury: Suppression of neutrophil activation during 72 hours of reperfusion
3. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: Role of neutrophil activation
4. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours o f regional ischemia and reperfusion: A demonstration of myocardial salvage
5. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs
6. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs
7. Glutathione repathway and reperfusion injury: Effect of N-acetylcysteine on infarct size and ventricular function
8. Superoxide dismutase reduced reperfusion arrhythmia but fails to salvage regional function or myocardium at risk in conscious dogs
9. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia-half reperfused and half not reperfused
10. Absence of lethal reperfusion injury after 3 hours of reperfusion. A study in a single-canine-heart model of ischemia-reperfusion
11. PEG-SOD and myocardial protection. Studies in the blood-and crystalloid-perfused rabbit and rat hearts
12. Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs
13. Preservation of high regional blood flow at epicardial rim after coronary occlusion in dogs
14. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity
15. Effect of mannitol in the prevention of evolving myocardial infarction
16. A rapid method for the analysis of creatine phosphokinase isoenzymes
17. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction
18. Ischemic preconditioning and infarct mass: The effect of hypercholesterolemia and endothelial dysfunction
19. Material administration of superoxide dismutase and catalase in phenytoin teratogenicity
20. Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart
21. The oxygen paradox: Two facets of the same problem?
22. Molecular oxygen. Friend and foe? The role of the oxygen free radical system in the calcium paradox, the paradox and ischemia/reperfusion injury
23. Reperfusion injury and its pharmacologic modification
24. Recombinant superoxide dismutase reduced oxygen free radical concentration in reperfused myocardium
25. Free radicals and myocardial ischemia and reperfusion injury
26. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of spin trap alpha-phenyl N-tert-buty nitrone
27. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion
28. Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction: Polyethlene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs
29. Superoxide dismutase conjugated to polyethlene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart